SIOC English
有机化学
高级检索

有机化学 >

2013 , Vol. 33 >Issue 10: 2226 - 2231

DOI: https://doi.org/10.6023/cjoc201305026

研究简报

超声辐射下O,O'-二烷基-α-取代苯基-α-苯磺酰氧基甲基膦酸酯的合成与生物活性

  • 杨家强 ,
  • 谷晴 ,
  • 胡月维 ,
  • 束波 ,
  • 宋宝安 ,
  • 刘静姿
展开
  • a 遵义医学院药学院 遵义 563003;
    b 遵义医学院生物化学与分子生物学教研室 遵义 563003;
    c 贵州大学精细化工研究中心 贵阳 550025

收稿日期: 2013-05-15

  修回日期: 2013-06-14

  网络出版日期: 2013-07-03

基金资助

国家自然科学基金(No. 81160385)和贵州省科技厅基金(No. 黔科合J字LKZ[2010]47)资助项目

收起

Synthesis of O,O'-Dialkyl-α-phenyl-α-phenylsulfonyloxy-methylphosphonate under Ultrasound and Their Antitumor Activity

  • Yang Jiaqiang ,
  • Gu Qing ,
  • Hu Yuewei ,
  • Shu Bo ,
  • Song Baoan ,
  • Liu Jingzi
Expand
  • a School of Pharmacy, Zunyi Medical College, Zunyi 563003;
    b Department of Biochemistry and Molecular Biology, Zunyi Medical College, Zunyi 563003;
    c Center for Research and Development of Fine Chemicals, Guizhou University, Guiyang 550025

Received date: 2013-05-15

  Revised date: 2013-06-14

  Online published: 2013-07-03

Supported by

Project supported by the National Natural Science Foundation of China (No. 81160385) and the Science and Technology Department of Guizhou Province (No. LKZ[2010]47).

Fold

摘要

结合药物设计原理, 对前期研究的活性结构类型进行优化. 在超声辐射下, 以α-羟基膦酸酯、苯磺酰氯为原料设计合成系列新型O,O'-二烷基-α-取代苯基-α-苯磺酰氧基甲基膦酸酯衍生物, 考察不同溶剂、反应温度、反应时间、反应功率对产率的影响, 得到最佳反应条件. 该方法简便可行、时间较短、产率较高. 目标物结构经1H NMR, IR, MS及元素分析确认, 并研究了质谱裂解规律. 初步生物活性测试表明: 部分目标物对肿瘤细胞A-549有较好的抑制作用.

关键词： α-羟基膦酸酯; 磺酸酯; 超声合成; 抗肿瘤活性

本文引用格式

杨家强 , 谷晴 , 胡月维 , 束波 , 宋宝安 , 刘静姿 . 超声辐射下O,O'-二烷基-α-取代苯基-α-苯磺酰氧基甲基膦酸酯的合成与生物活性[J]. 有机化学, 2013 , 33(10) : 2226 -2231 . DOI: 10.6023/cjoc201305026

Abstract

A series of O,O'-dialkyl-α-phenyl-α-phenylsulfonyloxy-methylphosphonates were synthesized from α-hydroxy-phosphonate and benzene sulfonyl chloride under ultrasound. Effects of different solvents, reaction time, reaction temperature and ultrasound power on the yield were investigated. The optimum reaction conditions were obtained. The method has some distinct advantages such as convenient, short reaction time and high yields. Their structures were clearly established by 1H NMR, IR, MS and elemental analysis, and the fragmentation pathways of them were studied. Preliminary results in bioactivity tests indicated that some title compounds exhibited better activity against A-549.

Key words： α-hydroxyphosphonate; sulfonate; ultrasonic synthesis; antitumor activity

参考文献

[1] (a) Huo, H.-W. World Pestic. 1999, 21, 21(in Chinese).
(贺红武, 世界农药, 1999, 21, 21.)
(b) Chen, R.-Y.; Liu, L.-Z. Research of the Organophosphorus Chemistry, Higher Education Press, Beijing, 2001, p. 49 (in Chinese).
(陈茹玉, 刘纶祖, 有机磷化学研究, 高等教育出版社, 北京, 2001, p. 49.)
(c) Hudson, H. R.; Yusuf, R. O.; Matthews, R. W. Phosphorus, Sulfur Silicon Relat. Elem. 2008, 83, 1527.
(d) Yang, J.-Q.; Song, B.-A.; Bhadury, P. S.; Chen, Z.; Yang, S.; Cai, X.-J.; Hu, D.-Y.; Xue, W. J. Agric. Food Chem. 2010, 58, 2730.
(e) Zhao, Y.-F.; Yan, X.-M.; Yang, C.-Y.; Han, S.-F.; Liu, Y. J. Xiamen Univ. (Nat. Sci.) 2011, 50, 319 (in Chinese).
(赵玉芬, 颜晓梅, 杨朝勇, 韩守法, 刘艳, 厦门大学学报(自然科学版), 2011, 50, 319.)
[2] Friedman, S. K. Semin. Oncol. 1978, 34, 193.
[3] Cheng, Y.-Y.; Huang,-L.; Lee, K. M.; Xu, J.-K.; Zheng, M.-H.; Kumta, S. M. Calcif. Tissue Int. 2004, 75, 71.
[4] Baulch-Brown, C.; Molloy, T. J.; Yeh, S. L.; Ma, D.; Spencer, A. Leuk Res. 2007, 31, 341.
[5] Song, B.-A.; Hong, Y.-P.; Jin, L.-H.; Yang, S.; Zou, Z.-H.; Hu, D.-Y.; He, W.; Liu, G.; Zhang, G.-P.; Li, Q.-Z. Chin. J. Org. Chem. 2005, 25, 1001 (in Chinese).
(宋宝安, 洪艳平, 金林红, 杨松, 邹志辉, 胡德禹, 何伟, 刘刚, 张国平, 李黔柱, 有机化学, 2005, 25, 1001.)
[6] Jin, L.-H.; Song, B.-A.; Zhang, G.-P.; Xu, R.-Q.; Zhang, S.-M.; Gao, X.-W.; Hu, D.-Y.; Yang, S. Bioorg. Med. Chem. Lett. 2006, 16, 1537.
[7] Liu, J.-Z.; Song, B.-A.; Fan, H.-T.; Bhadury, P.-S.; Wan, W.-T.; Yang, S.; Xu, W.-M.; Wu, J.; Jin, L.-H.; Xue, W.; Hu, D.-Y.; Zeng, S. Eur. J. Med. Chem. 2010, 45, 5108.
[8] Yang, J.-Q.; Gu, Q.; Shu, B.; Song, B.-A.; Liu, J.-Z. Chin. J. Org. Chem. 2013, 33, 1113 (in Chinese).
(杨家强, 谷晴, 束波, 宋宝安, 刘静姿, 有机化学, 2013, 33, 1113.)
[9] Khalaf, R. A.; Sheikha, G. A. MedChemRes 2011, 11, 1.
[10] Yan, L.; Müller, C. E. J. Med. Chem. 2004, 47, 1031.
[11] Straukas, J.; Dirvianskyte, N.; Astrauskas, V.; Butkus, E. Farmaco 2002, 57, 803.
[12] Elder, D. P.; Snodin, D. J. J. Pharm. Pharmacol. 2009, 61, 269.
[13] Hillisch, A.; Peters, O.; Gege, C.; Regenhardt, W.; Kosemund, D.; Siemeister, G.; Unger, E.; Bothe, U. CN 1751059, 2004 [Chem. Abstr. 2004, 141, 243723].
[14] Ahmed, S.; Shahid, I.; Dhanani, S.; Owen, C. P. Bioorg. Med. Chem. Lett. 2009, 19, 4698.
[15] Owen, C. P.; Shahid, I.; Lee, W. Y.; Ahmed, S. Bioorg. Med. Chem. Lett. 2010, 20, 5345.
[16] Los, M.; Burek, C. J.; Stroh, C.; Benedyk, K.; Hug, H.; Mackiewicz, A. Drug Discovery Today 2003, 8, 67.
[17] Higa, G.-M.; Abraham, J. Expert Rev. Anticancer Ther. 2007, 7, 1183.
[18] Zhang, S.-M.; Li, H.; Zheng, X.-C.; Li, B.-Q.; Wu, S.-H.; Huang, W.-P.; Liu, Z.-G.; Feng, Y. Chin. J. Org. Chem. 2002, 22, 603 (in Chinese).
(张守民, 李鸿, 郑修成, 李保庆, 吴世华, 黄唯平, 刘助国, 冯云, 有机化学, 2002, 22, 603.)
[19] Li, Y.-J.; Sun, Y.-Z.; Jin, K.; Xu, Y.-T.; Sun, S.-Q. Chin. J. Org. Chem. 2008, 28, 1074 (in Chinese).
(李英俊, 孙亚珍, 靳焜, 许永廷, 孙淑琴, 有机化学, 2008, 28, 1074.)
[20] Mccommbit, H.; Sauaders, B. C. J. Chem. Soc. 1945, 67, 380. Chen, Z.-X.; Jiang, L.-F.; Ding, T.-F.; Xu, Y.; Sun, L.; Yu, X.-Y. Chin. J. Chem. Eng. 2004, 18(2), 254 (in Chinese).
(陈钟秀, 蒋林峰, 丁同富, 徐 芸, 孙镭, 俞兴源, 高校化学工程学报, 2004, 18(2), 254.)
Options
文章导航

/

〈 〉